Lotte Biologics USA, LLC401(k)
LOTTE BIOLOGICS 401(K) PLAN · EAST SYRACUSE, NY · plan year 2024
Lotte Biologics USA, LLC's 2024 Form 5500 did not separately report plan administrative expenses, which is common where recordkeeping is paid through investment revenue-sharing or a master trust. The plan held $74,767,186 across 513 participant accounts, with employer contributions averaging $11,765 per active participant. See methodology for what Form 5500 does and doesn't capture.
The plan sits in the $50M–$250M size bracket, benchmarked here against 10,352 comparable plans and shown alongside other manufacturing employers. By assets it is the 1,004th-largest of 5,648 plans among New York employers on file, and the 2,341st of 13,661 in manufacturing. In 2024, the employer put in $1.07 for every $1.00 employees contributed themselves.
Lotte Biologics USA, LLC's 2024 employer contribution ran above the $3,635 median for plans its size, placing it in the top quarter of its peers. Filings report dollars actually contributed, not the match formula; the formula itself (for example, 50% of the first 6% of pay) lives in the plan's summary plan description from HR.
Compensation shown is direct payments from plan assets reported on Schedule C. Providers paid through fund revenue-sharing appear as indirect.
Why are you looking at this plan?
Source: U.S. Department of Labor, Form 5500 series, EIN 883288202 · Verify on EFAST2 · Amounts are as reported by the plan sponsor for the plan year shown.